Antiarrhythmia drugs for cardiac arrest: A systemic review and meta-analysis

Critical Care

Volumn 17, Issue 4, 2013, Pages

  Huang, Yu ^a   He, Qing ^a,b   Yang, Min ^b,c   Zhan, Lei ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Antiarrhythmia agents; Cardiopulmonary resuscitation; Heart arrest; Outcome assessment

Indexed keywords

ADRENALIN; AMIODARONE; ANTIARRHYTHMIC AGENT; BRETYLIUM; DOFETILIDE; IBUTILIDE; LIDOCAINE; MAGNESIUM SULFATE; NIFECALANT; NIFEKALANT; PLACEBO; POTASSIUM CHANNEL BLOCKING AGENT; SOTALOL; UNCLASSIFIED DRUG;

ARTICLE; CONTINUOUS INFUSION; ELECTRIC SHOCK; EMERGENCY WARD; GLASGOW COMA SCALE; HEART ARREST; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; META ANALYSIS; OUT OF HOSPITAL CARDIAC ARREST; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPEATED DRUG DOSE; RESUSCITATION; RETURN OF SPONTANEOUS CIRCULATION; RISK FACTOR; SHORT TERM SURVIVAL; SURVIVAL; SYSTEMATIC REVIEW; OBSERVATIONAL STUDY; PROCEDURES;

ANTI-ARRHYTHMIA AGENTS; HEART ARREST; HUMANS; OBSERVATIONAL STUDY AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84881298675     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12852     Document Type: Article

References (28)

1. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P,. American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006, 113:e85-e151. 10.1161/CIRCULATIONAHA.105.171600, 16407573, American Heart Association Statistics Committee and Stroke Statistics Subcommittee.
2. Vaillancourt C, Stiell IG. Cardiac arrest care and emergency medical services in Canada. Can J Cardiol 2004, 20:1081-1090.
3. Atwood C, Eisenberg MS, Herlitz J, Rea TD. Incidence of EMS-treated out-of hospital cardiac arrest in Europe. Resuscitation 2005, 67:75-80. 10.1016/j.resuscitation.2005.03.021, 16199289.
4. Nichol G, Thomas E, Callaway CW, Hedges J, Powell JL, Aufderheide TP, Rea T, Lowe R, Brown T, Dreyer J, Davis D, Idris A, Stiell I,. Resuscitation Outcomes Consortium Investigators Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA 2008, 300:1423-1431. 10.1001/jama.300.12.1423, 3187919, 18812533, Resuscitation Outcomes Consortium Investigators.
5. Deakin CD, Nolan JP, Soar J, Sunde K, Koster RW, Smith GB, Perkins GD. European Resuscitation Council guidelines for resuscitation, Section 4: adult advanced life support. Resuscitation 2010, 2010(81):1305-1352.
6. Neumar RW, Otto CW, Link MS, Kronick SL, Shuster M, Callaway CW, Kudenchuk PJ, Ornato JP, McNally B, Silvers SM, Passman RS, White RD, Hess EP, Tang W, Davis D, Sinz E, Morrison LJ. Part 8: Adult advanced cardiovascular life support, American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010, 2010(122):S729-S767.
7. Camm AJ, Lip GY, Caterina DR, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. Eur Heart J 2012, 33:2623-2630.
8. Katoh T, Mitamura H, Matsuda N, Takano T, Ogawa S, Kasanuki H. Emergency treatment with nifekalant, a novel class III anti-arrhythmic agent, for life-threatening refractory ventricular tachyarrhythmias post-marketing special investigation. Circ J 2005, 69:1237-1243. 10.1253/circj.69.1237, 16195624.
9. Yusu S, Ikeda T, Mera H, Miyakoshi M, Miwa Y, Abe A, Tsukada T, Ishiguro H, Shimizu H, Yoshino H. Effects of intravenous nifekalant as a lifesaving drug for severe ventricular tachyarrhythmias complicating acute coronary syndrome. Circ J 2009, 73:2021-2028. 10.1253/circj.CJ-09-0375, 19724153.
10. Higgins JPT, Altman DG, Sterne JAC. Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011) 2011, The Cochrane Collaboration, Higgins JPT, Green S, Available from http://www.cochrane-handbook.org.
11. Kudenchuk PJ, Cobb LA, Copass MK, Cummins RO, Doherty AM, Fahrenbruch CE, Hallstrom AP, Murray WA, Olsufka M, Walsh T. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999, 341:871-878. 10.1056/NEJM199909163411203, 10486418.
12. Skrifvars MB, Kuisma M, Boyd J, Määttä T, Repo J, Rosenberg PH, Castren M. The use of undiluted amiodarone in the management of out-of-hospital cardiac arrest. Acta Anaesthesiol Scand 2004, 48:582-587. 10.1111/j.0001-5172.2004.00386.x, 15101852.
13. Hassan TB, Jagger C, Barnett DB. A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation. Emerg Med J 2002, 19:57-62. 10.1136/emj.19.1.57, 1725791, 11777881.
14. Allegra J, Lavery R, Cody R, Birnbaum G, Brennan J, Hartman A, Horowitz M, Nashed A, Yablonski M. Magnesium sulfate in the treatment of refractory ventricular fibrillation in the prehospital setting. Resuscitation 2001, 49:245-249. 10.1016/S0300-9572(00)00375-0, 11719117.
15. Fatovich D, Prentice D, Dobb G. Magnesium in in-hospital cardiac arrest (the MAGIC trial). Resuscitation 1997, 35:237-241. 10.1016/S0300-9572(97)00062-2, 10203402.
16. Thel MC, Armstrong AL, McNulty SE, Califf RM, O'Connor CM. Randomised trial of magnesium in in-hospital cardiac arrest: Duke Internal Medicine Housestaff. Lancet 1997, 350:1272-1276. 10.1016/S0140-6736(97)05048-4, 9357406.
17. Harrison EE. Lidocaine in prehospital countershock refractory ventricular fibrillation. Ann Emerg Med 1981, 10:420-423. 10.1016/S0196-0644(81)80309-5, 7258756.
18. Herlitz J, Ekström L, Wennerblom B, Axelsson A, Bång A, Lindkvist J. Lidocaine in out-of-hospital ventricular fibrillation: does it improve survival?. Resuscitation 1997, 33:199-205. 10.1016/S0300-9572(96)01018-0, 9044490.
19. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 2002, 346:884-890. 10.1056/NEJMoa013029, 11907287.
20. Rea RS, Kane-Gill SL, Rudis MI, Seybert AL, Oyen LJ, Ou NN. Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias. Crit Care Med 2006, 34:1617-1623. 10.1097/01.CCM.0000217965.30554.D8, 16614583.
21. Amino M, Yoshioka K, Opthof T, Morita S, Uemura S, Tamura K, Fukushima T, Higami S, Otsuka H, Akieda K, Shima M, Fujibayashi D, Hashida T, Inokuchi S, Kodama I, Tanabe T. Comparative study of nifekalant versus amiodarone for shock-resistant ventricular fibrillation in out-of-hospital cardiopulmonary arrest patients. J Card Pharmacol 2010, 55:391-398.
22. Shiga T, Tanaka K, Kato R, Amino M, Matsudo Y, Honda T, Sagara K, Takahashi A, Katoh T, Urashima M, Ogawa S, Takano T, Kasanuki H. Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia. Resuscitation 2010, 81:47-52. 10.1016/j.resuscitation.2009.09.027, 19913983.
23. Tahara Y, Kimura K, Kosuge M, Ebina T, Sumita S, Hibi K, Toyama H, Kosuge T, Moriwaki Y, Suzuki N, Sugiyama M, Umemura S. Comparison of nifekalant and lidocaine for the treatment of shock-refractory ventricular fibrillation. Circ J 2006, 70:442-446. 10.1253/circj.70.442, 16565562.
24. Igarashi M, Fujino T, Toyoda M, Sugino K, Sasao K, Sasamoto S, Otsuka T, Kobayashi K, Okano Y, Yosiwara K, Koyama N. Defibrillation effects of intravenous nifekalant in patients with out-of-hospital ventricular fibrillation. Pac Clin Elec 2005, 28:S155-S157.
25. Olson DW, Thompson BM, Darin JC, Milbrath MH. A randomized comparison study of bretylium tosylate and lidocaine in resuscitation of patients from out-of-hospital ventricular fibrillation in a paramedic system. Ann Emerg Med 1984, 13:807-810. 10.1016/S0196-0644(84)80444-8, 6383135.
26. Nowak RM, Bodnar TJ, Dronen S, Gentzkow G, Tomlanovich MC. Bretylium tosylate as initial treatment for cardiopulmonary arrest: randomized comparison with placebo. Ann Emerg Med 1981, 10:404-407. 10.1016/S0196-0644(81)80306-X, 7258754.
27. Kovoor P, Love A, Hall J, Kruit R, Sadick N, Ho D, Adelstein BA, Ross DL. Randomized double-blind trial of sotalol versus lignocaine in out-of-hospital refractory cardiac arrest due to ventricular tachyarrhythmia. Intern Med J 2005, 35:518-525. 10.1111/j.1445-5994.2005.00896.x, 16105152.
28. Larabee TM, Liu KY, Campbell JA, Little CM. Vasopressors in cardiac arrest: a systematic review. Resuscitation 2012, 83:932-939. 10.1016/j.resuscitation.2012.02.029, 22425731.